Overview


An increasing number of tests related to mycobacteriology parasitology and virus is paving the way for microbiology testing. Microbiology testing can be used to test for microorganisms in biological samples, food and beverage samples, and environmental samples. Different methods can be used for microbiology testing, including molecular, chemical, molecular, and biochemical. Market growth is being driven by the increasing incidence of chronic and acute diseases around the world. Market growth is directly affected in part by rising incidences of HIV, malaria, tuberculosis, and pneumonia, along with increasing epidemics and outbreaks. The lucrative market growth opportunity will also be created by rising expenditure on research and development, particularly in developing and developed countries. Market growth is also being supported by increased research and development efforts for advanced technologies integration in healthcare facilities, and the detection of infectious diseases. Additionally, lucrative market growth opportunities will arise from both private and public players in the healthcare sector, particularly in developing economies. Markets will also benefit from high returns on investments, which can be attributed to research activities.
Market growth is positively influenced by an increasing number of orthopedic or cardiac surgeries, a rise in personal disposable income levels, the introduction of technologically driven medical products in hospitals, rising investment in advanced medical products and device development, and increased food safety concerns. Technology advancements in microbiology testing are key to the market's growth. Also, there is a rising incidence of infectious diseases and epidemics. There is also a growing private-public funding of research on infectious diseases. There are many serious and fatal STDs such as HIV and human papillomavirus, HPV, and Hepatitis B/C. This is why the market for microbiology testing has been growing. The growth of the microbiology market is also being driven by rising healthcare expenditures and improved medical infrastructures like hospitals and clinical labs. The market for microbiology testing is experiencing rapid growth due to the growing geriatric population and the increasing number of clinical researches in clinical microbiology. There are also rising rates of infectious diseases.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Microbial Testing Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Microbial Testing Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

• Bio-Rad Laboratories Inc.
• Abbott Laboratories
• Becton Dickinson and Company
• F.Hoffmann-La Roche Ltd
• Bruker Corporation
• Hologic Corporation
• Danaher Corporation (Cepheid Inc.)
• Biomerieux SA
• Thermo Fisher Scientific Inc.
• Agilent Technologies Inc.
• Merck KGaA
• Shimadzu Corporation
• NEOGEN Corporation
(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product
• Laboratory Instruments
o Incubators
o Gram Strainers
o Bacterial Colony Counters
o Autoclave Sterilizers
o Microbial Air Samplers
o Anaerobic Culture Systems
o Perti Dis Fillers
o Blood Culture Systems
o Microbial Culture Systems
o Other Laboratory Instruments
• Microbiology Analyzers
o Molecular Diagnostic Instruments
o Microscopes
o Mass Spectrometers
• Reagents
o Pathogen Specific Kits
o General Reagents
By Disease Area
• Respiratory Diseases
• Bloodstream Infections
• Gastrointestinal Diseases
• Sexually Transmitted Diseases
• Urinary Tract Infections
• Periodontal Diseases
• Other Diseases
By Application
• Pharmaceutical
• Clinical
• Food Testing
• Energy
• Chemical and Material manufacturing
• Environment
By Region
• North America
• Europe
• Asia-Pacific
Latin America
• Middle East and Africa

• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

• To provide with an exhaustive analysis on the Microbial Testing Market By Product, By Disease Area, By Application and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Microbial Testing Market Variables, Trends
    • Scope
        1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances
  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Microbial Testing Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Microbial Testing Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Microbial Testing Market, By Product Historical Analysis and Forecast 2022-2028 (USD Million)
    •   1. Laboratory Instruments
         1.1. Incubators
         1.2. Gram Strainers
         1.3. Bacterial Colony Counters
         1.4. Autoclave Sterilizers
         1.5. Microbial Air Samplers
         1.6. Anaerobic Culture Systems
         1.7. Perti Dis Fillers
         1.8. Blood Culture Systems
         1.9. Microbial Culture Systems
         1.10. Other Laboratory Instruments
        2. Microbiology Analyzers
         2.1. Molecular Diagnostic Instruments
         2.2. Microscopes
         2.3. Mass Spectrometers
        3. Reagents
         3.1. Pathogen Specific Kits
         3.2. General Reagents
  • 8.   Microbial Testing Market, By Disease Area Historical Analysis and Forecast 2022-2028 (USD Million)
    •   1. Respiratory Diseases
        2. Bloodstream Infections
        3. Gastrointestinal Diseases
        4. Sexually Transmitted Diseases
        5. Urinary Tract Infections
        6. Periodontal Diseases
        7. Other Disease
  • 9.   Microbial Testing Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million)
    •   1. Pharmaceutical
        2. Clinical
        3. Food Testing
        4. Energy
        5. Chemical and Material manufacturing
        6. Environment
  • 10.   North America Microbial Testing Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
           2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2022-2028
  • 11.   Latin America Microbial Testing Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2022-2028
  • 12.   Europe Microbial Testing Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. Germany
          2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2022-2028
  • 13.   Asia Pacific Microbial Testing Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
  • 14.   Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2022-2028
  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Bio-Rad Laboratories Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Abbott Laboratories
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Becton Dickinson and Company
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
         4. F. Hoffmann-La Roche Ltd
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Bruker Corporation
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Hologic Corporation
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Danaher Corporation (Cepheid Inc.)
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Biomerieux SA
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Thermo Fisher Scientific Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Agilent Technologies Inc.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Merck KGaA
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Shimadzu Corporation
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. NEOGEN Corporation
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients